Skip to search formSkip to main contentSkip to account menu

Alendronate

Known as: 4-Amino-1-Hydroxybutylidene 1,1-Biphosphonate, (4-Amino-1-hydroxybutylidene)bisphosphonic Acid, Aminohydroxybutane Bisphosphonate 
A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as… 
National Institutes of Health

Related topics

Related topics

21 relations

Narrower (3)

5-FdU-alendronateAlendronate SodiumMaxmarvil
Alendronic acidAlendronic acid 35 MG Oral TabletDrug AllergyEsophageal Achalasia

Broader (3)

Bone Density Conservation AgentsDiphosphonatesantagonists & inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Alendronate Use Among 812 Women: Prevalence of Gastrointestinal Complaints, Noncompliance with Patient Instructions, and Discontinuation
ABSTRACT: The objective of this study was to determine the extent to which women who receive alendronate therapy for osteoporosis… 
2012
2012
PEGylated Versus Non-PEGylated ó Fe2O3@Alendronate Nanoparticles
Thanks to their magnetic properties, superparamagnetic iron oxide nanoparticles are considered as a good delivery vehicle after… 
2011
2011
Multiple miliary osteoma cutis of the face after initiation of alendronate therapy for osteoporosis.
A 62-year-old Asian woman presented with multiple small, rock-hard papular lesions on her face (Figure). She had no previous… 
2010
2010
More on the Resolution of Bisphosphonate-associated Osteonecrosis of the Jaw
To the Editor: We thank Drs. Duck-An Kim and Think-You Kim for their comments about our article1. We agree that hepatitis test… 
Review
2010
Review
2010
Risk of atypical femoral fracture with long-term use of alendronate (bisphosphonates) : a systemic review of literature.
Several recent reports have described "atypical" fractures of the subtrochanteric and diaphyseal femoral shaft that occur with… 
2009
2009
Treatment with a Potent Cathepsin K Inhibitor Preserves Cortical and Trabecular Bone Mass in Ovariectomized Monkeys
The cysteine protease cathepsin K is involved in osteoclast-mediated bone resorption. We evaluated the effect of daily oral… 
2007
2007
Treatments for osteoporosis - looking beyond the HORIZON.
Bisphosphonates are an important option for the prevention of fractures in postmenopausal women. However, the complex… 
2000
2000
Effect of Alendronate Treatment on the Clinical Picture and Bone Turnover Markers in Chronic Idiopathic Hyperphosphatasia
Chronic idiopathic hyperphosphatasia (CIH), also known as juvenile Paget's disease, is characterized by increased bone turnover… 
1996
1996
Three-year follow-up on effects of transdermal estrogen.
1996
1996
Monosodium 4‐Amino‐1‐hydroxy‐1,1‐butanediyldiphosphonate Trihydrate (Alendronate)
The cation in the title compound, Na+.C4H12NO7P2−.3H2O, has the expected zwitterionic character, with a terminal protonated amine… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)